ITGR: 4Q22 Earnings Conference Call / February 16, 2023 / Page 2 Forward-Looking Statements This presentation contains summarized information concerning Integer Holdings Corporation (the "Company") and its business, operations, financial performance and trends. The historical financial and operating data contained herein reflect the consolidated results of the Company for the periods indicated. No representation is made that the information in this presentation is complete. For additional financial and busi ...

Integer Holdings Corporation (NYSE:ITGR) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Tony Borowicz - Senior Vice President of Investor Relations Joe Dziedzic - President and Chief Executive Officer Jason Garland - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Operator Hello, everyone, and welcome to the Integer Holdings Corporation's Fourth Quarter 2022 Earnings Conference Call. All lines have been placed on ...

Integer Holdings Corporation (NYSE:ITGR) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Anthony Borowicz - Senior Vice President, Investor Relations Joe Dziedzic - President and Chief Executive Officer Jason Garland - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Jim Sidoti - Sidoti Operator Good day and welcome to the Integer Holdings Corporation Third Quarter 2022 Earnings Release Conference Call. Please note t ...

ITGR: 3Q22 Earnings Conference Call / October 27, 2022 / Page 1 3Q22 Earnings Conference Call October 27, 2022 Integer Holdings Corporation Third Quarter 2022 Earnings Conference Call 9 a.m. Eastern Time, October 27, 2022 Speakers: Joe Dziedzic President and Chief Executive Officer Jason Garland Executive Vice President, Chief Financial Officer Tony Borowicz Senior Vice President, Investor Relations • A webcast of today's call can be accessed in the "Investor Relations" section of the Company's website: inv ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q _____________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number 1-16137 ________________________________________________ ...

Integer Holdings Corporation (NYSE:ITGR) Q2 2022 Earnings Conference Call July 28, 2022 12:00 PM ET Company Participants Tony Borowicz - Senior Vice President, Investor Relations Joe Dziedzic - President and Chief Executive Officer Jason Garland - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Jim Sidoti - Sidoti & Company Operator Ladies and gentlemen, thank you for standing by. My name is Brent and I will be your conference operator today. At thi ...

Integer Holdings Corp (NYSE:ITGR) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Anthony Borowicz - SVP, IR Joseph Dziedzic - President, CEO & Director Jason Garland - EVP & CFO Conference Call Participants Matthew Mishan - KeyBanc Capital Markets James Sidoti - Sidoti & Company Robert Wasserman - The Benchmark Company Operator Good day. My name is Savannah, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Integer Holdin ...

ITGR: 1Q22 Earnings Conference Call / April 28, 2022 / Page 1 1Q22 Earnings Conference Call April 28, 2022 | --- | --- | --- | --- | |-------|-------|-------|--------------------------------------------------------------------------| | | | | | | | | | Integer Holdings Corporation First Quarter 2022 Earnings Conference Call | | | | | 9 a.m. Eastern Time, April 28, 2022 | Speakers: Joe Dziedzic President and Chief Executive Officer Jason Garland Executive Vice President, Chief Financial Officer Tony Borowicz ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM 10-K _____________________________________ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ ...

Financial Performance - 4Q21 sales increased by 16% compared to 4Q20, and adjusted EPS increased by 39% compared to 4Q20[8] - Full year 2021 sales increased by 14% and adjusted EPS increased by 47% compared to 2020[8] - The company generated $157 million cash flow from operations in the full year[87] 2022 Outlook - The company projects sales of $1340 - $1365 million, representing a 10%-12% increase, with organic growth of 5%-7%[8] - Adjusted EBITDA is expected to be $270 - $282 million, up 11%-16%[8] - Adjusted EPS is projected to be $435 - $465, up 7%-14%[8] Strategy and Investment - The company aims for sales growth 200 basis points above the market and operating profit at 2x the sales growth rate[10] - The company is exiting approximately $40 million of Portable Medical sales over 4 years, which is expected to be margin accretive[20] - The company is increasing investments in capabilities and capacity in high-growth markets[25] Product Line Performance - Cardio & Vascular trailing four quarter sales increased 10% year-over-year in 4Q21[71] - CRM&N trailing four quarter sales increased 29% year-over-year in 4Q21[72] - Advanced Surgical, Orthopedics & Portable Medical trailing four quarter sales declined 10% year-over-year in 4Q21[74] - Electrochem trailing four quarter sales increased 8% year-over-year in 4Q21[75]